To amend the Federal Food, Drug, and Cosmetic Act to require notifications to the Food and Drug Administration regarding food substances generally recognized as safe, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The Better Food Disclosure Act of 2025 (Better FDA Act) overhauls how the FDA regulates food substances that companies currently self-certify as Generally Recognized As Safe (GRAS). Under current law, companies can independently determine that a food substance is GRAS without notifying the FDA. This bill eliminates that self-certification loophole by requiring all GRAS substances to be submitted to and listed by the FDA within 2 years. Any GRAS substance not on the FDA list would be deemed unsafe and illegal to use in food.
The bill also creates a new postmarket assessment process (Section 409B) allowing the FDA to reevaluate the safety of already-approved food additives, color additives, and GRAS substances based on citizen petitions, state official notices, or the FDA's own initiative.
Who Benefits and How
Consumers and public health advocates benefit from significantly increased FDA oversight of food substances. Thousands of chemicals currently used in food with only industry self-certification will now require FDA review and public listing.
State government officials gain a formal mechanism to petition FDA for safety reevaluations of food substances, giving them a direct role in food safety oversight.
FDA career scientists are specifically protected in the bill: safety determinations must be reviewed by career appointees with relevant scientific expertise, not political appointees.
Who Bears the Burden and How
Food manufacturers and ingredient suppliers face the largest compliance burden. Every GRAS substance currently in use must be submitted to the FDA within 2 years, and new substances must be submitted 120 days before first use. Companies whose substances are excluded must either request reconsideration, file a formal food additive petition, or phase out the substance.
The FDA faces a massive new regulatory workload: reviewing potentially thousands of GRAS notifications within 180-day windows, establishing and maintaining a public GRAS list, and conducting postmarket reevaluations.
Key Provisions
- Mandatory GRAS listing: All GRAS substances deemed unsafe unless on FDA list within 2 years (Section 409A)
- New substance pre-notification: Must notify FDA 120 days before first use of new GRAS substance (Section 409A)
- 180-day review clock: FDA must act on submissions within 180 days or substance is auto-listed (Section 409A)
- Postmarket reevaluation: FDA can reassess safety of any food additive, color additive, or GRAS substance via citizen petition or own initiative (Section 409B)
- Career scientist protection: Safety decisions must be reviewed by FDA career appointees, not political appointees (Section 409B)
- Phase-out option: Companies with excluded substances can request reconsideration, file food additive petition, or submit phase-out plan (Section 409A)
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Replaces the voluntary GRAS (Generally Recognized As Safe) notification system for food substances with a mandatory FDA listing requirement and establishes a postmarket reassessment process for food additives, color additives, and GRAS substances.
Key Policy Areas
Healthcare, Consumer Protection, Government Operations
Primary Purpose
Replaces the voluntary GRAS (Generally Recognized As Safe) notification system for food substances with a mandatory FDA listing requirement and establishes a postmarket reassessment process for food additives, color additives, and GRAS substances.
Policy Domains
Mandatory GRAS Reporting and FDA Listing (Section 409A)
Identified Gains
Contextual inference, no direct clause citation- Consumers
- Public health organizations
- Food safety advocates
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Food manufacturers
- Food ingredient suppliers
- FDA
Contextual inference, no direct clause citation
Postmarket Assessment of Food Substances (Section 409B)
Identified Gains
Contextual inference, no direct clause citation- Consumers
- State government officials
- FDA career scientists
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Food manufacturers with challenged substances
- FDA (postmarket review workload)
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
IntroducedMr. Marshall (for himself, Mrs. Britt, and Mr. Scott of …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
FDA, FDA career scientists, FDA political appointees
Color additive manufacturers, Food additive manufacturers, Food ingredient suppliers
Food manufacturers, Food manufacturers with challenged substances
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → Secretary of Health and Human Services (via FDA)
- "the_secretary"
- → Secretary of Health and Human Services (via FDA)
Key Definitions
Terms defined in this bill
Any substance whose intended use results in it becoming a component of food, if generally recognized by qualified experts as safe through scientific procedures (or pre-1958 common use), excluding food additives subject to Section 409.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology